CorMedix (CRMD) Earnings Date & Reports

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

CRMD is expected to report earnings to fall 63.90% to 10 cents per share on August 07

Q2'25

Est.

$0.11

Q1'25

Beat

by $0.14

Q4'24

Beat

by $0.05

Q3'24

Beat

by $0.06

Q2'24

Est.

$-0.25

The last earnings report on May 06 showed earnings per share of 30 cents, beating the estimate of 15 cents. With 137.71K shares outstanding, the current market capitalization sits at 833.57M.

View a ticker or compare two or three

Compare

CRMD